semaglutide renal impairment dosing just got FDA-approved for kidney disease. This changes everything. January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in type 2 diabetes with CKD. This Effects of Semaglutide on Chronic

doi: 10.1080/00365510802632155

Clinical trials have demonstrated consistent weight reduction in obese and overweight participants, with some experiencing a notable decrease in body mass index (BMI)

GLP-1 RAs have become cornerstone therapies for obesity and T2DM

Creatinine and eGFR: These tests show how well your kidneys are cleaning your blood

The primary evidence-based interventions are fluid, gradually increased soluble fiber, physical activity, and osmotic laxatives when needed, in consultation with the prescribing clinician

Even the highest-quality supplement can struggle to keep up if these lifestyle factors are present: Excessive Alcohol: Alcohol puts a massive oxidative burden on the liver and is a primary depleter of glutathione